Все публикации

0:04:46

First-Line Nivolumab/Ipilimumab Improves Survival in Unresectable Hepatocellular Carcinoma

0:07:52

Nivo+Gem/Cis Is Durable, Improves Survival in Patients With Lymph Node–Only mUC

0:06:00

Osimertinib Improves PFS in EGFR-Mutant, Unresectable, Stage III NSCLC

0:05:08

Consolidation Durvalumab Could Be New SOC in Limited-Stage SCLC

0:04:11

CROSS Inferior to FLOT in Patients With Esophageal Adenocarcinoma

0:05:52

Telehealth Equally Effective as In-Person Palliative Care in Maintaining QOL in Advanced Lung Cancer

0:06:43

Neoadjuvant Nivolumab + Ipilimumab Could Be New SOC in Stage III Melanoma

0:03:32

Adagrasib Improves PFS in Patients With KRASG12C-Mutated NSCLC

0:04:55

Amivantamab + Lazertinib Administration Method May Affect Outcomes in Advanced NSCLC

0:00:44

What Makes #ASCOQTLY24 a Must-Attend Meeting

0:00:46

Global Volunteer Month 2024

0:00:57

Dr. Angela DeMichele on Why You Should Attend Our Flagship Best of ASCO Meeting

0:00:37

#ASCOBT24: Bringing International Colleagues to the APAC Region

0:00:28

#ASCOBT24: Explore What We Have Planned for You

0:01:49

Dr. Melvin Chua Invites You to Register for #ASCOBT24

0:00:48

Hear From Past Attendees on Why You Can't Miss #ASCOBT24

0:00:28

Help Shine A Light on Advances in Cancer Care: Register for #ASCOBT24

0:00:28

Why You Should Submit to #ASCOBT24 With Dr. Van Leyfman

0:00:28

Help Shine A Light on Advances in Cancer Care: Submit to #ASCOBT24

0:00:55

Save the Date for #ASCOBT24 August 8-10, 2024, in Yokohama, Japan

0:03:32

Dr. Melvin Chua on Why You Can't Miss #ASCOBT24

0:02:46

Systemic Treatment of Patients with Metastatic Breast Cancer: ASCO Resource-Stratified Guideline

0:02:16

Regional Affiliate Program

0:00:56

Find a World of Inspiration at #ASCO24